Mike Overton Ph.D.
Associate Dean Continuous Quality Improvement
Job Description
Dr. Overton serves as the Associate Dean for CQI. He oversees monitoring of compliance with LCME accrediation and coordinates strategic planning. He is a Professor in the Department of Biomedical Sciences having previously directed a NIH funded research program that advanced the understanding of regulation of energy balance and cardiovascuclar function in rodent models.. He is the Co-Block Director for the Renal-Urinary and Cardiovascular-Pulmonary Blocks and teaches cardiovascular, pulmonary and renal physiology. He also serves as Chairman of the Curriculum Committee.
Biosketch
Dr. Overton received his B.S. degree in Biological Sciences from FSU and his Ph.D. degree in Exercise Sciences from the University of Iowa. He obtained postdoctoral training in pharmacology at the University of Arizona and came to FSU as an assistant profesor in 1992. He served as the Betty Watts Professor and as chair of the Department of Nutrition, Food and Exercise Science before joining the College of Medicine in 2005. He served as interim chair of the Department of Biomedical Sciences in 2009-2010.
Education
B.S. in Biological Sciences (1980), Florida State University
Ph.D. in Exercise Science (1987), University of Iowa
Postdoctoral training in pharmacology (1988-1990),University of Arizona
Service
University Service:
Biomedical Advisory Committee (BAC; 2001-2015)
BAC chair (2006-2012)
Faculty Rep, GPC Review Committee of Biomedical Sciences (2011–2012)
Faculty Rep, GPC Review Committee of Psychology (2009–2010)
AAU membership Task Force (2005)
Pathways of Excellence Executive Committee (2005-06)
Search Committee for Director of LAR (2007-08)
Professional
Peer Review Committee, American Heart Assoc., Fl. Affiliate, 1993-97 (Vice-Chairman:1995-96; Chairman:1996-97)
Peer Review, Southern Consortium, AHA 1997-98, 1999-02
Research Policy and Guidelines Review Task Force, American Heart Assoc. Fl. Affiliate, 1995-6
Research Committee, American Heart Assoc., Fl. Affiliate, 1995-02 (vice chair, 1998-99; chair, 2000-02)
Public Advocacy Committee, Florida Affiliate of the Am. Heart Assoc, 1998-2002
Science Integration Committee, Fl.-Puerto Rico AHA; Chair: 2001-03
Honors/Awards
Developing Scholar Award (1996), Florida State University
Research Career Enhancement Award (1996), American Physiological Society
American Heart Association (2001), Gold Affiliate Service Award
Betty Watts Professorship (2004-05), Florida State University
Fellow (2007), American Heart Association and Council for High Blood Pressure
Courses
Renal-Urinary Co-Course Director Cardiovascular-Pulmonary Co-Course Director
Publications
Overton, J. M., Maloney SK, Fuller A, Mitchell D, & Gordon C. (2014). Translating Animal Model Research: Does it Matter That Our Rodents are Cold? Physiology (Besthesda), Review, 413-420.
Dweck D, Sanchess-Gonzalez MA, Chang AN, Dulce RA, Badger CD, Koutnick AP, Ruiz EL, Griffin B, Liang J, Kabbaj M, Fincham FD, Hare JM, Overton, JM, & Pinto JR. (2014). Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy. J Biol Chem, 8/15/2014, 289(33): 23097-111. doi:10.1074
Overton, J. M., Tucker K, & Fadool DA. (2014). Diet-Induced obesity resistance of KV1, 3-/-mice is olfactory bulb dependent. J Neuroendocrinol, 1365-2826. doi:10.1111/j.1365-2826.2014.02314.x.
Tucker, K., Cavallin, M. A., Jean-Baptiste, P., Biju, K. C., Overton, J. M., Pedarazani, P., & Fadool, D. A. (2012). Diet-induced obesity resistance of Kv1.3-/- mice is olfactory bulb dependent. Journal of Neuroendocrinology, 24, 1087-95.
Knight, W. D., Witte, M. M., Parsons, A. D., Gierach, M., & Overton, J. M. (2011). Long-term caloric restriction reduces metabolic rate and heart rate under cool and thermoneutral conditions in FBNF1 rats. Mech Ageing Dev, 132(5), 220-9.
Overton, J. M. (2010). Phenotyping small animals as models for the human metabolic syndrome: thermoneutrality matters. Int J Obes (Lond), 34 Suppl 2, S53-8.
Seth, R., Knight, W. D., & Overton, J. M. (2010). Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats. Int J Obes (Lond), 35: 1183-92.
Dr. Overton serves as the Associate Dean for CQI. He oversees monitoring of compliance with LCME accrediation and coordinates strategic planning. He is a Professor in the Department of Biomedical Sciences having previously directed a NIH funded research program that advanced the understanding of regulation of energy balance and cardiovascuclar function in rodent models.. He is the Co-Block Director for the Renal-Urinary and Cardiovascular-Pulmonary Blocks and teaches cardiovascular, pulmonary and renal physiology. He also serves as Chairman of the Curriculum Committee.
Dr. Overton received his B.S. degree in Biological Sciences from FSU and his Ph.D. degree in Exercise Sciences from the University of Iowa. He obtained postdoctoral training in pharmacology at the University of Arizona and came to FSU as an assistant profesor in 1992. He served as the Betty Watts Professor and as chair of the Department of Nutrition, Food and Exercise Science before joining the College of Medicine in 2005. He served as interim chair of the Department of Biomedical Sciences in 2009-2010.
B.S. in Biological Sciences (1980), Florida State University
Ph.D. in Exercise Science (1987), University of Iowa
Postdoctoral training in pharmacology (1988-1990),University of Arizona
University Service:
Biomedical Advisory Committee (BAC; 2001-2015)
BAC chair (2006-2012)
Faculty Rep, GPC Review Committee of Biomedical Sciences (2011–2012)
Faculty Rep, GPC Review Committee of Psychology (2009–2010)
AAU membership Task Force (2005)
Pathways of Excellence Executive Committee (2005-06)
Search Committee for Director of LAR (2007-08)
Professional
Peer Review Committee, American Heart Assoc., Fl. Affiliate, 1993-97 (Vice-Chairman:1995-96; Chairman:1996-97)
Peer Review, Southern Consortium, AHA 1997-98, 1999-02
Research Policy and Guidelines Review Task Force, American Heart Assoc. Fl. Affiliate, 1995-6
Research Committee, American Heart Assoc., Fl. Affiliate, 1995-02 (vice chair, 1998-99; chair, 2000-02)
Public Advocacy Committee, Florida Affiliate of the Am. Heart Assoc, 1998-2002
Science Integration Committee, Fl.-Puerto Rico AHA; Chair: 2001-03
Developing Scholar Award (1996), Florida State University
Research Career Enhancement Award (1996), American Physiological Society
American Heart Association (2001), Gold Affiliate Service Award
Betty Watts Professorship (2004-05), Florida State University
Fellow (2007), American Heart Association and Council for High Blood Pressure
Renal-Urinary Co-Course Director Cardiovascular-Pulmonary Co-Course Director
Overton, J. M., Maloney SK, Fuller A, Mitchell D, & Gordon C. (2014). Translating Animal Model Research: Does it Matter That Our Rodents are Cold? Physiology (Besthesda), Review, 413-420.
Dweck D, Sanchess-Gonzalez MA, Chang AN, Dulce RA, Badger CD, Koutnick AP, Ruiz EL, Griffin B, Liang J, Kabbaj M, Fincham FD, Hare JM, Overton, JM, & Pinto JR. (2014). Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy. J Biol Chem, 8/15/2014, 289(33): 23097-111. doi:10.1074
Overton, J. M., Tucker K, & Fadool DA. (2014). Diet-Induced obesity resistance of KV1, 3-/-mice is olfactory bulb dependent. J Neuroendocrinol, 1365-2826. doi:10.1111/j.1365-2826.2014.02314.x.
Tucker, K., Cavallin, M. A., Jean-Baptiste, P., Biju, K. C., Overton, J. M., Pedarazani, P., & Fadool, D. A. (2012). Diet-induced obesity resistance of Kv1.3-/- mice is olfactory bulb dependent. Journal of Neuroendocrinology, 24, 1087-95.
Knight, W. D., Witte, M. M., Parsons, A. D., Gierach, M., & Overton, J. M. (2011). Long-term caloric restriction reduces metabolic rate and heart rate under cool and thermoneutral conditions in FBNF1 rats. Mech Ageing Dev, 132(5), 220-9.
Overton, J. M. (2010). Phenotyping small animals as models for the human metabolic syndrome: thermoneutrality matters. Int J Obes (Lond), 34 Suppl 2, S53-8.
Seth, R., Knight, W. D., & Overton, J. M. (2010). Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats. Int J Obes (Lond), 35: 1183-92.